Annual Operating Expenses
$31.11 M
+$2.87 M+10.16%
December 31, 2023
Summary
- As of February 23, 2025, RGLS annual total operating expenses is $31.11 million, with the most recent change of +$2.87 million (+10.16%) on December 31, 2023.
- During the last 3 years, RGLS annual operating expenses has risen by +$6.95 million (+28.76%).
- RGLS annual operating expenses is now -62.38% below its all-time high of $82.70 million, reached on December 31, 2016.
Performance
RGLS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$15.21 M
+$2.95 M+24.06%
September 30, 2024
Summary
- As of February 23, 2025, RGLS quarterly total operating expenses is $15.21 million, with the most recent change of +$2.95 million (+24.06%) on September 30, 2024.
- Over the past year, RGLS quarterly operating expenses has stayed the same.
- RGLS quarterly operating expenses is now -39.20% below its all-time high of $25.02 million, reached on June 30, 2015.
Performance
RGLS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
RGLS Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.2% | 0.0% |
| 3 y3 years | +28.8% | 0.0% |
| 5 y5 years | -33.6% | 0.0% |
RGLS Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +11.8% | at high | +131.5% |
| 5 y | 5-year | at high | +31.4% | at high | +241.6% |
| alltime | all time | -62.4% | +48.7% | -39.2% | +241.6% |
Regulus Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.21 M(+24.1%) |
| Jun 2024 | - | $12.26 M(+38.9%) |
| Mar 2024 | - | $8.83 M(+6.3%) |
| Dec 2023 | $31.11 M(+10.2%) | $8.30 M(+2.2%) |
| Sep 2023 | - | $8.13 M(+11.1%) |
| Jun 2023 | - | $7.32 M(-0.7%) |
| Mar 2023 | - | $7.37 M(+6.3%) |
| Dec 2022 | $28.24 M(+1.5%) | $6.93 M(-8.3%) |
| Sep 2022 | - | $7.56 M(+5.4%) |
| Jun 2022 | - | $7.17 M(+9.2%) |
| Mar 2022 | - | $6.57 M(-5.6%) |
| Dec 2021 | $27.82 M(+15.1%) | $6.96 M(-17.3%) |
| Sep 2021 | - | $8.42 M(+26.8%) |
| Jun 2021 | - | $6.64 M(+14.5%) |
| Mar 2021 | - | $5.80 M(-3.8%) |
| Dec 2020 | $24.16 M(+2.1%) | $6.03 M(-1.1%) |
| Sep 2020 | - | $6.09 M(-6.2%) |
| Jun 2020 | - | $6.50 M(+17.2%) |
| Mar 2020 | - | $5.54 M(+24.4%) |
| Dec 2019 | $23.67 M(-49.5%) | $4.45 M(-11.1%) |
| Sep 2019 | - | $5.01 M(+6.9%) |
| Jun 2019 | - | $4.69 M(-50.8%) |
| Mar 2019 | - | $9.52 M(+18.9%) |
| Dec 2018 | $46.84 M(-33.3%) | $8.00 M(-19.0%) |
| Sep 2018 | - | $9.87 M(-26.1%) |
| Jun 2018 | - | $13.36 M(-14.4%) |
| Mar 2018 | - | $15.60 M(+13.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $70.20 M(-15.1%) | $13.72 M(-11.1%) |
| Sep 2017 | - | $15.43 M(-27.7%) |
| Jun 2017 | - | $21.34 M(+8.2%) |
| Mar 2017 | - | $19.71 M(-0.3%) |
| Dec 2016 | $82.70 M(+9.5%) | $19.76 M(+1.9%) |
| Sep 2016 | - | $19.40 M(-10.5%) |
| Jun 2016 | - | $21.67 M(-0.9%) |
| Mar 2016 | - | $21.87 M(+20.0%) |
| Dec 2015 | $75.52 M(+43.6%) | $18.22 M(+19.8%) |
| Sep 2015 | - | $15.21 M(-39.2%) |
| Jun 2015 | - | $25.02 M(+46.5%) |
| Mar 2015 | - | $17.07 M(+24.1%) |
| Dec 2014 | $52.58 M(+40.7%) | $13.75 M(+7.9%) |
| Sep 2014 | - | $12.74 M(-7.3%) |
| Jun 2014 | - | $13.75 M(+11.5%) |
| Mar 2014 | - | $12.34 M(+21.9%) |
| Dec 2013 | $37.37 M(+47.9%) | $10.12 M(+12.1%) |
| Sep 2013 | - | $9.02 M(-4.5%) |
| Jun 2013 | - | $9.45 M(+7.5%) |
| Mar 2013 | - | $8.79 M(+16.5%) |
| Dec 2012 | $25.27 M(+20.8%) | $7.54 M(+18.9%) |
| Sep 2012 | - | $6.34 M(+8.1%) |
| Jun 2012 | - | $5.87 M(+6.2%) |
| Mar 2012 | - | $5.52 M(+5.4%) |
| Dec 2011 | $20.93 M(-13.2%) | $5.24 M(+9.6%) |
| Sep 2011 | - | $4.78 M |
| Dec 2010 | $24.10 M | - |
FAQ
- What is Regulus Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Regulus Therapeutics?
- What is Regulus Therapeutics annual operating expenses year-on-year change?
- What is Regulus Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Regulus Therapeutics?
- What is Regulus Therapeutics quarterly operating expenses year-on-year change?
What is Regulus Therapeutics annual total operating expenses?
The current annual operating expenses of RGLS is $31.11 M
What is the all time high annual operating expenses for Regulus Therapeutics?
Regulus Therapeutics all-time high annual total operating expenses is $82.70 M
What is Regulus Therapeutics annual operating expenses year-on-year change?
Over the past year, RGLS annual total operating expenses has changed by +$2.87 M (+10.16%)
What is Regulus Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of RGLS is $15.21 M
What is the all time high quarterly operating expenses for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly total operating expenses is $25.02 M
What is Regulus Therapeutics quarterly operating expenses year-on-year change?
Over the past year, RGLS quarterly total operating expenses has changed by $0.00 (0.00%)